Zevra Therapeutics
ZVRA----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Zevra Therapeutics(ZVRA) predict that the Revenue is 36.22 M (+77.54%), Beat estimate;the EBIT is 52.15 M (+1073%), Beat estimate;the EPS is 0.6 (+1100%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.04B77.54%
0.03B56.66%
+0.00B20.88%
EBITExceed expectations
0.05B1072.51%
0.01B221.14%
+0.05B851.37%
EPSExceed expectations
0.61100.00%
0.09250.00%
+0.5100850.00%
Upcoming earnings report - FY2026 Q2 Earning Release
Available dateAug 5, 2026
Estimate Revenue33.89 M
Estimate EBIT6.912 M
Estimate EPS0.1088
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf